BACKGROUND: Global brain abnormalities such as brain volume loss and grey- and white-matter deficits are consistently reported in first-episode schizophrenia patients and may already be detectable in the very early stages of the illness. Whether these changes are dependent on medication use or related to intelligence quotient (IQ) is still debated. METHOD: Magnetic resonance imaging scans were obtained for 20 medication-naive patients with first-episode schizophrenia and 26 matched healthy subjects. Volume measures of total brain grey and white matter, third and lateral ventricles and cortical thickness/surface were obtained. Differences between the groups were investigated, taking into account the effect of intelligence. RESULTS: Medication-naive patients showed statistically significant reductions in whole-brain volume and cerebral grey- and white-matter volume together with lateral ventricle enlargement compared to healthy subjects. IQ was significantly lower in patients compared to controls and was positively associated with brain and white-matter volume in the whole group. No significant differences in cortical thickness were found between the groups but medication-naive patients had a significantly smaller surface in the left superior temporal pole, Heschl's gyrus and insula compared to controls. CONCLUSIONS: Our findings suggest that brain volume loss is present at illness onset, and can be explained by the reduced surface of the temporal and insular cortex. These abnormalities are not related to medication, but IQ.
BACKGROUND: Global brain abnormalities such as brain volume loss and grey- and white-matter deficits are consistently reported in first-episode schizophreniapatients and may already be detectable in the very early stages of the illness. Whether these changes are dependent on medication use or related to intelligence quotient (IQ) is still debated. METHOD: Magnetic resonance imaging scans were obtained for 20 medication-naive patients with first-episode schizophrenia and 26 matched healthy subjects. Volume measures of total brain grey and white matter, third and lateral ventricles and cortical thickness/surface were obtained. Differences between the groups were investigated, taking into account the effect of intelligence. RESULTS: Medication-naive patients showed statistically significant reductions in whole-brain volume and cerebral grey- and white-matter volume together with lateral ventricle enlargement compared to healthy subjects. IQ was significantly lower in patients compared to controls and was positively associated with brain and white-matter volume in the whole group. No significant differences in cortical thickness were found between the groups but medication-naive patients had a significantly smaller surface in the left superior temporal pole, Heschl's gyrus and insula compared to controls. CONCLUSIONS: Our findings suggest that brain volume loss is present at illness onset, and can be explained by the reduced surface of the temporal and insular cortex. These abnormalities are not related to medication, but IQ.
Authors: Toshiyuki Ohtani; Elisabetta Del Re; James J Levitt; Margaret Niznikiewicz; Jun Konishi; Takeshi Asami; Toshiro Kawashima; Tomohide Roppongi; Paul G Nestor; Martha E Shenton; Dean F Salisbury; Robert W McCarley Journal: Brain Struct Funct Date: 2018-04-18 Impact factor: 3.270
Authors: Sonja M C de Zwarte; Rachel M Brouwer; Andromachi Tsouli; Wiepke Cahn; Manon H J Hillegers; Hilleke E Hulshoff Pol; René S Kahn; Neeltje E M van Haren Journal: Schizophr Bull Date: 2019-10-24 Impact factor: 9.306
Authors: Valerie M Anderson; Meghan E Goldstein; Robert R Kydd; Bruce R Russell Journal: Int J Neuropsychopharmacol Date: 2015-02-25 Impact factor: 5.176
Authors: James A Karantonis; Sean P Carruthers; Susan L Rossell; Christos Pantelis; Matthew Hughes; Cassandra Wannan; Vanessa Cropley; Tamsyn E Van Rheenen Journal: Schizophr Bull Date: 2021-10-21 Impact factor: 7.348
Authors: Theo G M van Erp; Esther Walton; Derrek P Hibar; Lianne Schmaal; Wenhao Jiang; David C Glahn; Godfrey D Pearlson; Nailin Yao; Masaki Fukunaga; Ryota Hashimoto; Naohiro Okada; Hidenaga Yamamori; Juan R Bustillo; Vincent P Clark; Ingrid Agartz; Bryon A Mueller; Wiepke Cahn; Sonja M C de Zwarte; Hilleke E Hulshoff Pol; René S Kahn; Roel A Ophoff; Neeltje E M van Haren; Ole A Andreassen; Anders M Dale; Nhat Trung Doan; Tiril P Gurholt; Cecilie B Hartberg; Unn K Haukvik; Kjetil N Jørgensen; Trine V Lagerberg; Ingrid Melle; Lars T Westlye; Oliver Gruber; Bernd Kraemer; Anja Richter; David Zilles; Vince D Calhoun; Benedicto Crespo-Facorro; Roberto Roiz-Santiañez; Diana Tordesillas-Gutiérrez; Carmel Loughland; Vaughan J Carr; Stanley Catts; Vanessa L Cropley; Janice M Fullerton; Melissa J Green; Frans A Henskens; Assen Jablensky; Rhoshel K Lenroot; Bryan J Mowry; Patricia T Michie; Christos Pantelis; Yann Quidé; Ulrich Schall; Rodney J Scott; Murray J Cairns; Marc Seal; Paul A Tooney; Paul E Rasser; Gavin Cooper; Cynthia Shannon Weickert; Thomas W Weickert; Derek W Morris; Elliot Hong; Peter Kochunov; Lauren M Beard; Raquel E Gur; Ruben C Gur; Theodore D Satterthwaite; Daniel H Wolf; Aysenil Belger; Gregory G Brown; Judith M Ford; Fabio Macciardi; Daniel H Mathalon; Daniel S O'Leary; Steven G Potkin; Adrian Preda; James Voyvodic; Kelvin O Lim; Sarah McEwen; Fude Yang; Yunlong Tan; Shuping Tan; Zhiren Wang; Fengmei Fan; Jingxu Chen; Hong Xiang; Shiyou Tang; Hua Guo; Ping Wan; Dong Wei; Henry J Bockholt; Stefan Ehrlich; Rick P F Wolthusen; Margaret D King; Jody M Shoemaker; Scott R Sponheim; Lieuwe De Haan; Laura Koenders; Marise W Machielsen; Therese van Amelsvoort; Dick J Veltman; Francesca Assogna; Nerisa Banaj; Pietro de Rossi; Mariangela Iorio; Fabrizio Piras; Gianfranco Spalletta; Peter J McKenna; Edith Pomarol-Clotet; Raymond Salvador; Aiden Corvin; Gary Donohoe; Sinead Kelly; Christopher D Whelan; Erin W Dickie; David Rotenberg; Aristotle N Voineskos; Simone Ciufolini; Joaquim Radua; Paola Dazzan; Robin Murray; Tiago Reis Marques; Andrew Simmons; Stefan Borgwardt; Laura Egloff; Fabienne Harrisberger; Anita Riecher-Rössler; Renata Smieskova; Kathryn I Alpert; Lei Wang; Erik G Jönsson; Sanne Koops; Iris E C Sommer; Alessandro Bertolino; Aurora Bonvino; Annabella Di Giorgio; Emma Neilson; Andrew R Mayer; Julia M Stephen; Jun Soo Kwon; Je-Yeon Yun; Dara M Cannon; Colm McDonald; Irina Lebedeva; Alexander S Tomyshev; Tolibjohn Akhadov; Vasily Kaleda; Helena Fatouros-Bergman; Lena Flyckt; Geraldo F Busatto; Pedro G P Rosa; Mauricio H Serpa; Marcus V Zanetti; Cyril Hoschl; Antonin Skoch; Filip Spaniel; David Tomecek; Saskia P Hagenaars; Andrew M McIntosh; Heather C Whalley; Stephen M Lawrie; Christian Knöchel; Viola Oertel-Knöchel; Michael Stäblein; Fleur M Howells; Dan J Stein; Henk S Temmingh; Anne Uhlmann; Carlos Lopez-Jaramillo; Danai Dima; Agnes McMahon; Joshua I Faskowitz; Boris A Gutman; Neda Jahanshad; Paul M Thompson; Jessica A Turner Journal: Biol Psychiatry Date: 2018-05-14 Impact factor: 12.810